Hjem › Kronisk progressiv multipel sklerose › Arizona
Kronisk progressiv multipel sklerose kliniske forsøg i Arizona
4 studier for Kronisk progressiv multipel sklerose søger deltagere på steder i Arizona.
Byer i Arizona
Officiel studietekst (engelsk)
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Arizona Neuroscience Research, LLC, Phoenix
- Perseverance Research Center, LLC (PRC), Scottsdale
RekruttererFase 3
Alder 18 til 60 · Alle køn · Opdateret 30. sep. 2026 · NCT07299019A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Clinical Endpoints, LLC, Scottsdale
RekruttererFase 4
Alder 18 til 65 · Alle køn · Opdateret 30. sep. 2026 · NCT07609719A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Arizona Neuroscience Research, LLC, Pheonix
- Perseverance Research Center, Scottsdale
RekruttererFase 3
Alder 18 til 60 · Alle køn · Opdateret 22. sep. 2026 · NCT07067463A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Ctr for Neurology and Spine, Phoenix
- AZ Integrated Neuro and Spine, Phoenix
- Center for Neurosciences, Tucson
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 29. jul. 2026 · NCT07225504Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.